Pharmacologic management of feline lower urinary tract disorders.
Pharmacological recommendations for the treatment of lower urinary tract disorders in cats are rapidly evolving as more is learned about the physiology and pathophysiology of the feline urinary bladder and urethra. Recent investigations and clinical observations have led to reconsideration of previously prescribed treatments and to the use of new and alternative pharmacologic agents. Pharmacologic agents used in the management of common lower urinary tract disorders in cats, including urinary tract infections, idiopathic lower urinary tract inflammation, urinary incontinence, urine retention, and urinary elimination disorders, are reviewed.
Lane
I F
IF
Department of Companion Animals, Atlantic Veterinary College, University of Prince Edward Island, Canada.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D018678:Cholinergic Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D014549:Urinary Incontinence / Q000188:drug therapy / Q000662:veterinary; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000662:veterinary*; D014570:Urologic Diseases / Q000188:drug therapy / Q000662:veterinary*
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D018678:Cholinergic Agents; D018680:Cholinergic Antagonists; D005938:Glucocorticoids; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D010406:Penicillins